JHS Svendgaard Laboratories' Q2 FY 2025-26 Quarterly Results

Result Summary

• JHS Svendgaard Laboratories Ltd reported a 4.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 14.0%.
• Its expenses for the quarter were down by 1.7% QoQ and up 3.6% YoY.
• The net profit decreased 118.9% QoQ and decreased 98.1% YoY.
• The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd - at - during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

JHS Svendgaard Laboratories Ltd is a company involved in the manufacturing and marketing of oral care products. It operates within the consumer goods industry, primarily focusing on products such as toothbrushes, toothpaste, and other dental hygiene items. The company has established its presence in both the domestic and international markets, providing a range of oral care solutions. As of the latest updates, there are no specific major developments or announcements available for JHS Svendgaard Laboratories Ltd. The company continues its operations within the competitive landscape of the oral care industry, striving to maintain its market position among established and emerging players.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), JHS Svendgaard Laboratories Ltd reported a total income of ₹23.42 crores. This represents a decrease of 4.2% compared to the previous quarter (Q1FY26), where the total income was ₹24.45 crores. However, on a year-over-year (YoY) basis, the total income saw an increase of 14.0% from ₹20.54 crores in the second quarter of the fiscal year 2025 (Q2FY25). This reflects a notable improvement in revenue generation compared to the same period last year, despite the sequential decline from the prior quarter.

Profitability

The profitability metrics for JHS Svendgaard Laboratories Ltd in Q2FY26 present a mixed picture. The company reported a Profit Before Tax (PBT) of -₹0.02 crores, which is a significant decline from the PBT of ₹0.63 crores in Q1FY26, reflecting a quarter-over-quarter (QoQ) decline of 103.2%. Compared to Q2FY25, where the PBT was -₹2.07 crores, there is an improvement of 99.0% year-over-year (YoY). The Tax for Q2FY26 was ₹0.18 crores, contrasting with a tax benefit of -₹0.43 crores in Q1FY26 and a tax expense of ₹8.25 crores in Q2FY25. Profit After Tax (PAT) stood at -₹0.20 crores in Q2FY26, down from ₹1.06 crores in Q1FY26, resulting in a QoQ decrease of 118.9%. Compared to Q2FY25's PAT of -₹10.32 crores, there was a significant YoY improvement of 98.1%.

Operating Metrics

JHS Svendgaard Laboratories Ltd's operating metrics highlight the financial challenges and improvements over time. Total expenses for Q2FY26 were recorded at ₹23.43 crores, showing a modest decrease of 1.7% from ₹23.83 crores in Q1FY26. However, compared to the same quarter last year, there was a 3.6% increase from ₹22.62 crores in Q2FY25. The Earnings Per Share (EPS) for Q2FY26 was ₹0.00, down from ₹0.12 in Q1FY26, representing a 100.0% decrease quarter-over-quarter. Compared to Q2FY25, where EPS was -₹1.24, there was a 100.0% year-over-year improvement. These figures indicate the company's efforts in managing expenses and the resultant impact on earnings, despite the minimal changes in EPS this quarter.